FOXG1 syndrome

FOXG1 syndrome is a neurodevelopmental condition caused by a heterozygous pathogenic variant or deletion affecting FOXG1. Development, movement, communication, growth, sleep, feeding, vision, and seizure risk may be affected. The phenotype varies, including among people with similar variants. FOXG1 duplications can cause a related but distinct clinical pattern and require careful molecular interpretation.1

Urgent safety

Follow the person's seizure action plan. Call emergency services for a seizure that reaches the plan's emergency threshold, repeated seizures without recovery, breathing difficulty or color change, serious injury, or a first or substantially changed seizure. Do not give extra rescue medicine outside the prescribed plan.1

Seek urgent assessment for choking, inability to clear secretions, marked dehydration, acute loss of alertness or skills, or sustained painful posturing or movement that interferes with breathing, hydration, or sleep. Sudden change should not automatically be attributed to FOXG1 syndrome.

Clinical pattern and diagnosis

Possible features include:

• developmental and learning differences with speech that may be limited or absent;
• congenital or postnatal microcephaly and growth concerns;
• hypotonia, later spasticity, stereotyped movements, and hyperkinetic or dyskinetic movement disorders such as chorea and dystonia;
• feeding or swallowing difficulty, reflux, aspiration risk, and poor weight gain;
• seizures, disrupted sleep, strabismus, and episodes of unexplained crying or restlessness;
• characteristic but variable MRI findings involving the corpus callosum, cortical folding, frontal regions, or basal ganglia.

Diagnosis requires compatible clinical or imaging findings and a pathogenic or likely pathogenic FOXG1 variant. A variant of uncertain significance does not establish or exclude the diagnosis. MRI may support assessment but can be normal and is not diagnostic by itself.1

FOXG1 syndrome was historically called a “congenital variant of Rett syndrome.” That label is misleading: FOXG1 syndrome is a distinct condition, often with early hyperkinetic movement and without the classic Rett pattern of apparently typical early development followed by regression.1

Most cases are caused by a new autosomal-dominant variant, but parental or germline mosaicism and rare inherited variants affect recurrence counseling. Use the actual laboratory result and parental testing with a genetics professional.1

Treatment and follow-up

There is no established disease-modifying treatment. Care is directed to seizures, movement, tone, sleep, reflux, constipation, nutrition, swallowing, vision, orthopedic health, comfort, learning, and participation. Medication response and adverse effects vary; movement episodes should be characterized before they are treated as seizures or behavior.1

Current evidence suggests FOXG1 syndrome is generally a developmental encephalopathy rather than a progressive neurodegenerative disorder, but health, seizures, movement, comfort, and function can change. A new loss of ability warrants medical evaluation. Seating, mobility, splinting, exercise, and positioning require direct assessment rather than a diagnosis-based device list.

Feeding and communication

Feeding assessment should consider coughing, choking, respiratory symptoms, prolonged meals, fatigue, weight and hydration, reflux, constipation, movement, posture, and oral-motor function. Texture, pacing, positioning, equipment, tube feeding, and exercises require direct multidisciplinary assessment.1

Limited speech or hand use does not reveal how much a person understands or intends. Treat gaze, facial expression, body movement, vocalization, gesture, object use, and AAC as potential communication. Offer meaningful choices, allow processing time, and verify rather than guess.

Use multimodal AAC early and across settings. Options may include objects, tactile or auditory cues, partner-assisted scanning, gestures, pictures, switches, and speech-generating systems. Hyperkinetic movement, hand control, strabismus, visual attention, seating, fatigue, and seizure state can affect access; eye gaze is not an automatic solution. Trial options in familiar activities, train partners, include vocabulary beyond basic needs, establish urgent messages and a reliable yes/no response, and keep a low-tech backup.3 For evaluation, trials, funding, and implementation, use the AAC device acquisition guide.

Coding

• ICD-10-CM QA0.0151: FOXG1 syndrome.

This diagnosis-specific code became effective in FY2026. Code epilepsy and other associated conditions only when documented and supported by current local coding rules.4

Sources

1. Brockmann and Staudt. FOXG1 Syndrome, GeneReviews — current molecular diagnosis, phenotype, management, surveillance, prognosis limits, and genetic counseling (updated 2025).
2. Vegas et al. Delineating FOXG1 syndrome — clinical, imaging, movement, and genotype-phenotype variability (2018; PMID 30533527).
3. American Speech-Language-Hearing Association: Augmentative and Alternative Communication — individualized, multimodal AAC assessment without cognitive prerequisites.
4. Centers for Medicare & Medicaid Services: FY2026 ICD-10-CM definitions — QA0.0151 descriptor, displayed without punctuation as QA00151.

Review boundary

This page cannot diagnose FOXG1 syndrome, interpret a genetic variant, or remotely assess seizures, movement emergencies, swallowing, nutrition, pain, or respiratory risk. Emergencies require immediate local assessment. Rescue medication, other treatment, diet, equipment, mobility, and communication decisions require direct review by qualified clinicians with the person and family.